These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases. Shannon K; King A; Phillips I J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169 [TBL] [Abstract][Full Text] [Related]
11. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria. Pechère JC; Letarte R; Guay R; Asselin C; Morin C J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528 [No Abstract] [Full Text] [Related]
12. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic. Minamimura M; Taniyama Y; Inoue E; Mitsuhashi S Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389 [TBL] [Abstract][Full Text] [Related]
13. In-vitro antimicrobial activity of Sch 29842, a new beta-lactam antibiotic. Mitsuhashi S; Inoue M; Saino Y; Ogashiwa M J Antimicrob Chemother; 1982 Feb; 9 Suppl C():91-5. PubMed ID: 6977535 [No Abstract] [Full Text] [Related]
14. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Hanslo D; King A; Shannon K; Warren C; Phillips I J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426 [No Abstract] [Full Text] [Related]
15. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases. Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175 [TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases. Livermore DM; Williams RJ; Williams JD J Antimicrob Chemother; 1981 Nov; 8(5):355-62. PubMed ID: 6798011 [No Abstract] [Full Text] [Related]
17. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria. Sanders CC; Sanders WE J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534 [No Abstract] [Full Text] [Related]
18. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem. Qadri SM; Ueno Y; Burdette M; Kroschinsky R; Almodovar E Chemotherapy; 1991; 37(6):398-404. PubMed ID: 1760938 [TBL] [Abstract][Full Text] [Related]
19. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383. Basker MJ; Boon RJ; Hunter PA J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745 [TBL] [Abstract][Full Text] [Related]
20. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)]. Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824 [No Abstract] [Full Text] [Related] [Next] [New Search]